期刊文献+

HSP65-MUC1肿瘤疫苗对小鼠胰腺组织的分子模拟作用 被引量:1

Molecular mimicry of murine pancreas by HSP65-MUC1
下载PDF
导出
摘要 目的:探讨重组抗肿瘤融合蛋白疫苗热激蛋白65-黏蛋白1(HSP65-MUC1)在小鼠体内通过分子模拟方式损伤小鼠胰腺的可能性。方法:21只C57BL/6小鼠随机分为PBS对照组、HSP65组和HSP65-MUC1组(每组7只),分别皮下注射PBS、HSP65和HSP65-MUC1,每周1次,给药3周。无菌分离小鼠脾细胞,利用流式细胞术检测特异性淋巴细胞的增殖情况,组织病理学观察小鼠胰腺的病理改变。结果:流式细胞术检测,与PBS对照组和HSP65组比较,HSP65-MUC1肿瘤疫苗组HSP65-MUC1特异性淋巴细胞升高了16.88%(P<0.001);HSP65特异性淋巴细胞升高了7.29%(P<0.01);与HSP60交叉识别的特异性淋巴细胞升高了5.79%(P<0.05)。3个免疫组小鼠胰腺组织HE染色病理均正常。结论:HSP65-MUC1肿瘤疫苗没有通过分子模拟诱导损伤小鼠胰腺。 Objective To explore the possibility to damage mice pancreas by recombinant fusion protein vaccine,heat shock protein 65-mucin 1(HSP65-MUC1) via molecular mimicry.Methods 21 C57BL/6 mice were randomly divided into three groups:PBS control,HSP65 and HSP65-MUC1 groups.The mice in each group were injected underneath with PBS,HSP65 and HSP65-MUC1,respectively,once a week for three weeks.The mouse pancreas were isolated under aseptic situation,the proliferation of specific lymphocytes was tested by flow cytometry,the pathological changes of mouse pancreas were detected with histo-pathological analysis.Results By flow cytometry,compared with PBS and HSP65 groups,the lymphocytes specific to HSP65-MUC1 of mice in HSP65-MUC1 group were increased by 16.88%(P0.001),the lymphocytes specific to HSP65 were increased by 7.29 %(P0.01);the lymphocytes specific to HSP60 were increased by 5.79 %(P0.05).However,HE staining of mouse pancreas in immunized mice kept normal.Conclusion The mouse pancreas are not injured by HSP65-MUC1 via molecular mimicry.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2011年第1期15-17,F0002,共4页 Journal of Jilin University:Medicine Edition
基金 国家重点基础研究发展计划(973计划)项目资助课题(2001CB510007)
关键词 重组抗肿瘤融合蛋白 疫苗 热激蛋白65-黏蛋白1 分子模拟 recombinant fusion protein anti-tumor vaccines heat shock protein 65-mucin1 molecular mimicry
  • 相关文献

参考文献12

二级参考文献44

  • 1程晓丽,李春燕,连建华,齐华,刘永波.线粒体基质蛋白Hsp70、Hsp60的表达、纯化、鉴定及抗体制备[J].郑州大学学报(医学版),2006,41(6):1058-1060. 被引量:2
  • 2[1]ICH S7A.Safety pharmacology studies for human pharmaceuticals[EB/OL].http://www.fda.gov/cder/guidance/index.htm,2001-07-15.
  • 3[2]ICH S7B.Safety pharmacology studies for assessing the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals[EB/OL].http://www.fda.gov./cder/guidance/index.htm,2002-06-12.
  • 4[3]Murphy DJ.Safety pharmacology of the respiratory system:techniques and study design[J].Drug Dev Res,1994,32:237-246.
  • 5Iangezaal I, Coeeke S, Hartung J. Whole blood eytokine response as a measure of immunotoxieity. Toxieol in vitro, 2000,15:313-318.
  • 6Pieters R, Albers R. Assessment of autoimmunogenie potential of xenobiotics using the popliteal lymph node assay. Toxicol Method, 1999,19:71-77.
  • 7Biotechnology industry Organization. Biotechnology industry statistics, http ://www. bio. org/er/statisticsl, asp.
  • 8Cavagnaro JA. Preclinical safety evaluation of biotechnology-derived pharmaceuticals. Nat Rev Drug Disc,2002,1:469-475.
  • 9Sims J. Assessment of bioteehnology products for therapeutic use. Toxicol Lett, 2001,120 : 59-66.
  • 10Braun A, Kwee L, Labow MA,et al. Protein aggregates seem to play a key role among the parameter influencing the antigenicity of interferon-(INF-α) in normal and transgenic mice.Pharm Res, 1997,14: 1472-1478.

共引文献22

同被引文献12

  • 1侯俊玲,郑亚东,景志忠,才学鹏.DNA疫苗免疫佐剂的研究进展[J].中国兽医科技,2005,35(2):153-156. 被引量:5
  • 2靳彦文,曹诚,李平,刘萱,黄维,马清钧.热休克蛋白65增强小鼠对HBV DNA疫苗免疫反应的研究[J].军事医学科学院院刊,2006,30(1):11-14. 被引量:3
  • 3Miller P J, Afonso C L, Spackman E, et al. Evidence for a new avian paramyxovirus serotype 10 detected in 571 rockhopper penguinsfrom the Falkland isLands [ J ]. Virol, 2010, 573 ( 21 ) : 496-504.
  • 4Kapczynski D R, King D J. Protection of chickens against overt clinical disease and detemfination nf viral shedding following vaccination with conanercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak [ J ]. Vaccine, 2005, 23(34) :24-33.
  • 5Vogel F R, Sarver N. Nucleic acid vaccines [ J ]. Clin Microbiol Rev, 1995, 8(3): 406-410.
  • 6Sawant P M, Verma P C, Subudhi P K, et al. hnmunomodula- tion of bivalent Newcastle disease DNA vaccine induced immune response by co-delivery of chicken IFN-γ and IL-4 genes [ J ]. Veterinary Immunology and Immunopathology, 2011, 144: 36-44.
  • 7Okada M, Kita Y. Anti-tuberculosis immunity by cytoloxic T ceils granulysin and the development of novel vaccines ( HSP-65 DNA +1L-12 DNA)[J]. Kekkaku, 2010, 85(6):531-538.
  • 8Yang J, Xie Y, Wang H, et al. Administration of heat shock protein 65 inhibits routine melanoma growth in vivo [ J ]. Mol Med Report, 2012, 6: 1167.
  • 9Chen K, Lu J, Wang L, et al. Mycobacterial heat shock protein 65 enhances antigen cross-presentation in dendritic cells independent of Toll -like receptor 4 signaling [ J ]. Epub, 2004, 75 (2) : 260-266.
  • 10Hua Wang, Xuejin Su. Recombinant heat shock protein 65 carrying PADRE and HBV epitopes activates dendritic cells and elicits HBV-spe- eifie CTL responses[ J]. Vaccine, 2011, 29:2328-2335.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部